064550 — BioneerCorp Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapFalling Star

Annual cashflow statement for BioneerCorp, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-7,420	59,188	29,199	15,122	-6,919
Depreciation
Amortisation
Non-Cash Items	1,929	44,705	41,453	6,636	12,005
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-5,370	-13,563	-23,332	-21,023	-9,904
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-5,589	95,705	53,175	8,805	4,136
Capital Expenditures	-4,762	-56,752	-43,286	-18,524	-4,660
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-7,253	-3,736	-2,338	-625	-8,809
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities	-12,015	-60,488	-45,624	-19,149	-13,468
Financing Cash Flow Items	11,235	-16.3	-8.75	-5.81	-94.8
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	18,343	-5,952	7,753	4,674	14,055
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	730	27,924	16,726	-5,547	4,703